Allows BioPharmX to Leverage UPM’s Outsourced Manufacturing for
Anticipated High-Volume Consumer Product
BRISTOL, Tenn., (December 10, 2014 /PRNewswire/) − UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with BioPharmX, Inc. (OTCQB: BPMX) to commercially manufacture solid dose iodine supplement tablets for the consumer products sector. The.
Welcome to Gregory Pharmaceutical Holdings
Date: December 08, 2014
Comments: No Comments
Categories: Gregory Pharmaceuticals News
Welcome to Gregory Pharmaceutical Holdings. Check back for more news.